Literature DB >> 15151626

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

Seung Ha Park1, Byung Ik Kim, Jung Won Yun, Jeong Wook Kim, Dong Il Park, Yong Kyun Cho, In Kyung Sung, Chang Young Park, Chong Il Sohn, Woo Kyu Jeon, Hyang Kim, Eun Jung Rhee, Won Young Lee, Sun Woo Kim.   

Abstract

BACKGROUND AND AIM: Although insulin resistance is often considered the link between obesity and non-alcoholic fatty liver disease (NAFLD), the role of insulin resistance, independent of obesity, as a NAFLD risk factor in non-obese men has been less well established. Systemic inflammation may be accompanied by insulin resistance in healthy subjects. The goal of the present study was to examine if insulin resistance and systemic inflammatory markers are independent predictors of NAFLD in non-obese men.
METHODS: The authors conducted a cross-sectional survey of 120 patients with NAFLD and 240 controls matched by age and body mass index. Controls had no evidence of alcohol abuse, hepatitis B or C, obesity, or previous history of diabetes, fasting hyperglycemia or hypertension. Diagnosis of NAFLD was based on an elevated alanine aminotransferase level and sonographic evidence of a fatty liver. Insulin resistance was determined using a homeostasis model assessment (HOMA-IR).
RESULTS: The age-adjusted risk of developing NAFLD was strongly associated with the elevated levels in measurements of uric acid, fasting blood sugar, triglycerides, apolipoprotein B, C-reactive protein (CRP) and HOMA-IR, and decreased levels of high density lipoprotein cholesterol and apolipoprotein A-I. Multivariate analysis based on univariate analysis indicated that an increase in CRP (odds ratio [OR] = 1.37; 95% confidence interval [CI]: 1.06-1.77) per 1 SD (1.48 mg/L) and HOMA-IR (OR = 2.28; 95% CI: 1.67-3.11) per 1 SD (0.63) were independent risk factors for NAFLD.
CONCLUSION: Insulin resistance and systemic inflammatory response are of key importance for inducing NAFLD, particularly in apparently healthy non-obese men.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151626     DOI: 10.1111/j.1440-1746.2004.03362.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  60 in total

1.  Sonographic fatty liver, overweight and ischemic heart disease.

Authors:  Yu-Cheng Lin; Huey-Ming Lo; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

2.  The relationship between arterial stiffness and nonalcoholic fatty liver disease.

Authors:  Yong-Jae Lee; Jae-Yong Shim; Byung-Soo Moon; Youn-Ho Shin; Dong-Hyuk Jung; Jung-Hyun Lee; Hye-Ree Lee
Journal:  Dig Dis Sci       Date:  2011-07-13       Impact factor: 3.199

3.  Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice.

Authors:  Lei Zhao; Ya-Xi Chen; Zac Varghese; Ai-Long Huang; Ren-Kuan Tang; Bei Jia; John F Moorhead; Jian-Ping Gong; Xiong Z Ruan
Journal:  Hepatol Int       Date:  2011-06-24       Impact factor: 6.047

Review 4.  Chronic liver inflammation: clinical implications beyond alcoholic liver disease.

Authors:  Byoung-Jin Park; Yong-Jae Lee; Hye-Ree Lee
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.

Authors:  Alexandra Feldman; Sebastian K Eder; Thomas K Felder; Lyudmyla Kedenko; Bernhard Paulweber; Andreas Stadlmayr; Ursula Huber-Schönauer; David Niederseer; Felix Stickel; Simon Auer; Elisabeth Haschke-Becher; Wolfgang Patsch; Christian Datz; Elmar Aigner
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

Review 6.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

7.  Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.

Authors:  S H Lee; J M Yun; S H Kim; Y G Seo; H Min; E Chung; Y S Bae; I S Ryou; B Cho
Journal:  J Endocrinol Invest       Date:  2016-08-25       Impact factor: 4.256

8.  High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population.

Authors:  Tomomi Kogiso; Yuriko Moriyoshi; Satoru Shimizu; Hikaru Nagahara; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

9.  Association among C-reactive protein, Fatty liver disease, and cardiovascular risk.

Authors:  Javier Lizardi-Cervera; Norberto C Chavez-Tapia; Oliver Pérez-Bautista; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

10.  Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).

Authors:  Masato Yoneda; Takashi Uchiyama; Shingo Kato; Hiroki Endo; Koji Fujita; Kyoko Yoneda; Hironori Mawatari; Hiroshi Iida; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Shiro Maeyama; Mina Sagara; Hiroyuki Aburatani; Tatsuhiko Kodama; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2008-11-14       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.